title: [Pathopshysiological mechanisms in macular edema].
abstract: The treatment of diabetic macular edema has known a fast development in the last 5 years where the transition from laser monotherapy to intravitreal pharmacotherapy is becoming standard practice. Intravitreal injections therapy is in a continuous development with promising positive results. The use of intratvitreal devices in the treatment of macular edema of vascular cause has become a viable alternative also in treating diabetic macular edema. Several clinical studies have revealed the superiority of intravitreal treatment versus laser monotherapy. This article is evaluating and reviewing present and future treatments used to combat diabetic macular edema. [corrected].
authors.forename: Cristian
authors.initials: C
authors.lastname: Turlea
authors.forename: Ileana
authors.initials: I
authors.lastname: Zolog
authors.forename: Codruta
authors.initials: C
authors.lastname: Blăjan
authors.forename: C
authors.initials: C
authors.lastname: Roşca
authors.forename: Magdalena
authors.initials: M
authors.lastname: Turlea
authors.forename: Mihnea
authors.initials: M
authors.lastname: Munteanu
authors.forename: Ovidiu
authors.initials: O
authors.lastname: Boruga
mesh_terms: D003930:Diabetic Retinopathy / Q000150:complications; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D017075:Laser Coagulation / Q000379:methods; D008269:Macular Edema / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D012170:Retinal Vein Occlusion / Q000150:complications; D016896:Treatment Outcome; D015866:Uveitis, Posterior / Q000150:complications; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D005938:Glucocorticoids; D042461:Vascular Endothelial Growth Factor A